INNOSPEC INC (IOSP) Fundamental Analysis & Valuation

NASDAQ:IOSPUS45768S1050

Current stock price

73.02 USD
-0.17 (-0.23%)
At close:
73.02 USD
0 (0%)
After Hours:

This IOSP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. IOSP Profitability Analysis

1.1 Basic Checks

  • IOSP had positive earnings in the past year.
  • IOSP had a positive operating cash flow in the past year.
  • In the past 5 years IOSP has always been profitable.
  • Each year in the past 5 years IOSP had a positive operating cash flow.
IOSP Yearly Net Income VS EBIT VS OCF VS FCFIOSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

1.2 Ratios

  • IOSP's Return On Assets of 6.36% is amongst the best of the industry. IOSP outperforms 85.54% of its industry peers.
  • Looking at the Return On Equity, with a value of 8.79%, IOSP is in the better half of the industry, outperforming 77.11% of the companies in the same industry.
  • IOSP has a Return On Invested Capital of 9.99%. This is amongst the best in the industry. IOSP outperforms 83.13% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IOSP is above the industry average of 6.58%.
Industry RankSector Rank
ROA 6.36%
ROE 8.79%
ROIC 9.99%
ROA(3y)5.52%
ROA(5y)6.16%
ROE(3y)7.95%
ROE(5y)9.14%
ROIC(3y)10.49%
ROIC(5y)10.77%
IOSP Yearly ROA, ROE, ROICIOSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of IOSP (6.56%) is better than 77.11% of its industry peers.
  • In the last couple of years the Profit Margin of IOSP has grown nicely.
  • With a Operating Margin value of 9.69%, IOSP perfoms like the industry average, outperforming 54.22% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IOSP has grown nicely.
  • Looking at the Gross Margin, with a value of 27.69%, IOSP is in line with its industry, outperforming 51.81% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IOSP has remained more or less at the same level.
Industry RankSector Rank
OM 9.69%
PM (TTM) 6.56%
GM 27.69%
OM growth 3Y0.51%
OM growth 5Y9.09%
PM growth 3Y-1.07%
PM growth 5Y22.21%
GM growth 3Y-2.5%
GM growth 5Y-0.73%
IOSP Yearly Profit, Operating, Gross MarginsIOSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. IOSP Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IOSP is destroying value.
  • Compared to 1 year ago, IOSP has less shares outstanding
  • IOSP has more shares outstanding than it did 5 years ago.
  • IOSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IOSP Yearly Shares OutstandingIOSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
IOSP Yearly Total Debt VS Total AssetsIOSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • IOSP has an Altman-Z score of 4.69. This indicates that IOSP is financially healthy and has little risk of bankruptcy at the moment.
  • IOSP's Altman-Z score of 4.69 is amongst the best of the industry. IOSP outperforms 91.57% of its industry peers.
  • IOSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.69
ROIC/WACC0.63
WACC15.95%
IOSP Yearly LT Debt VS Equity VS FCFIOSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • IOSP has a Current Ratio of 2.79. This indicates that IOSP is financially healthy and has no problem in meeting its short term obligations.
  • IOSP has a better Current ratio (2.79) than 74.70% of its industry peers.
  • IOSP has a Quick Ratio of 1.88. This is a normal value and indicates that IOSP is financially healthy and should not expect problems in meeting its short term obligations.
  • IOSP has a Quick ratio of 1.88. This is in the better half of the industry: IOSP outperforms 73.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.88
IOSP Yearly Current Assets VS Current LiabilitesIOSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. IOSP Growth Analysis

3.1 Past

  • IOSP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.67%.
  • The Earnings Per Share has been growing by 10.48% on average over the past years. This is quite good.
  • IOSP shows a decrease in Revenue. In the last year, the revenue decreased by -3.65%.
  • Measured over the past years, IOSP shows a quite strong growth in Revenue. The Revenue has been growing by 8.31% on average per year.
EPS 1Y (TTM)-11.67%
EPS 3Y-4.32%
EPS 5Y10.48%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)-3.65%
Revenue growth 3Y-3.26%
Revenue growth 5Y8.31%
Sales Q2Q%-2.4%

3.2 Future

  • IOSP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.89% yearly.
  • The Revenue is expected to grow by 4.83% on average over the next years.
EPS Next Y-2.62%
EPS Next 2Y9.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.57%
Revenue Next 2Y4.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IOSP Yearly Revenue VS EstimatesIOSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
IOSP Yearly EPS VS EstimatesIOSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. IOSP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.78, which indicates a correct valuation of IOSP.
  • IOSP's Price/Earnings ratio is rather cheap when compared to the industry. IOSP is cheaper than 81.93% of the companies in the same industry.
  • IOSP is valuated rather cheaply when we compare the Price/Earnings ratio to 25.35, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 14.15, the valuation of IOSP can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IOSP indicates a somewhat cheap valuation: IOSP is cheaper than 68.67% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of IOSP to the average of the S&P500 Index (22.61), we can say IOSP is valued slightly cheaper.
Industry RankSector Rank
PE 13.78
Fwd PE 14.15
IOSP Price Earnings VS Forward Price EarningsIOSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IOSP is valued cheaply inside the industry as 87.95% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IOSP indicates a somewhat cheap valuation: IOSP is cheaper than 61.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.81
EV/EBITDA 7.05
IOSP Per share dataIOSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The decent profitability rating of IOSP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.31
EPS Next 2Y9.89%
EPS Next 3YN/A

7

5. IOSP Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.40%, IOSP has a reasonable but not impressive dividend return.
  • IOSP's Dividend Yield is a higher than the industry average which is at 2.04.
  • IOSP's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.4%

5.2 History

  • On average, the dividend of IOSP grows each year by 10.33%, which is quite nice.
  • IOSP has paid a dividend for at least 10 years, which is a reliable track record.
  • IOSP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.33%
Div Incr Years11
Div Non Decr Years11
IOSP Yearly Dividends per shareIOSP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 36.36% of the earnings are spent on dividend by IOSP. This is a low number and sustainable payout ratio.
  • The dividend of IOSP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP36.36%
EPS Next 2Y9.89%
EPS Next 3YN/A
IOSP Yearly Income VS Free CF VS DividendIOSP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
IOSP Dividend Payout.IOSP Dividend Payout, showing the Payout Ratio.IOSP Dividend Payout.PayoutRetained Earnings

IOSP Fundamentals: All Metrics, Ratios and Statistics

INNOSPEC INC

NASDAQ:IOSP (3/31/2026, 8:00:02 PM)

After market: 73.02 0 (0%)

73.02

-0.17 (-0.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-17
Earnings (Next)05-06
Inst Owners100.31%
Inst Owner Change-0.3%
Ins Owners1.28%
Ins Owner Change8.09%
Market Cap1.81B
Revenue(TTM)1.78B
Net Income(TTM)116.60M
Analysts82.22
Price Target101.32 (38.76%)
Short Float %1.31%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 2.4%
Yearly Dividend1.71
Dividend Growth(5Y)10.33%
DP36.36%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.09%
Min EPS beat(2)3.59%
Max EPS beat(2)18.6%
EPS beat(4)2
Avg EPS beat(4)4.49%
Min EPS beat(4)-2.48%
Max EPS beat(4)18.6%
EPS beat(8)4
Avg EPS beat(8)3.59%
EPS beat(12)7
Avg EPS beat(12)5.17%
EPS beat(16)10
Avg EPS beat(16)6.68%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-0.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-6.47%
Max Revenue beat(4)-0.96%
Revenue beat(8)1
Avg Revenue beat(8)-3.21%
Revenue beat(12)3
Avg Revenue beat(12)-2.87%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.59%
EPS NY rev (1m)-9.16%
EPS NY rev (3m)-9.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.79%
Revenue NY rev (1m)-1.41%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE 13.78
Fwd PE 14.15
P/S 1.02
P/FCF 28.81
P/OCF 13.08
P/B 1.36
P/tB 2.11
EV/EBITDA 7.05
EPS(TTM)5.3
EY7.26%
EPS(NY)5.16
Fwd EY7.07%
FCF(TTM)2.53
FCFY3.47%
OCF(TTM)5.58
OCFY7.64%
SpS71.75
BVpS53.51
TBVpS34.68
PEG (NY)N/A
PEG (5Y)1.31
Graham Number79.89
Profitability
Industry RankSector Rank
ROA 6.36%
ROE 8.79%
ROCE 11.7%
ROIC 9.99%
ROICexc 12.47%
ROICexgc 20.63%
OM 9.69%
PM (TTM) 6.56%
GM 27.69%
FCFM 3.53%
ROA(3y)5.52%
ROA(5y)6.16%
ROE(3y)7.95%
ROE(5y)9.14%
ROIC(3y)10.49%
ROIC(5y)10.77%
ROICexc(3y)12.93%
ROICexc(5y)12.84%
ROICexgc(3y)21.77%
ROICexgc(5y)21.32%
ROCE(3y)12.28%
ROCE(5y)12.6%
ROICexgc growth 3Y-5.87%
ROICexgc growth 5Y13.88%
ROICexc growth 3Y-6.44%
ROICexc growth 5Y15.2%
OM growth 3Y0.51%
OM growth 5Y9.09%
PM growth 3Y-1.07%
PM growth 5Y22.21%
GM growth 3Y-2.5%
GM growth 5Y-0.73%
F-Score7
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 173.17%
Cap/Sales 4.25%
Interest Coverage 250
Cash Conversion 64.09%
Profit Quality 53.86%
Current Ratio 2.79
Quick Ratio 1.88
Altman-Z 4.69
F-Score7
WACC15.95%
ROIC/WACC0.63
Cap/Depr(3y)170.94%
Cap/Depr(5y)141.98%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.27%
Profit Quality(3y)163.55%
Profit Quality(5y)115.68%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.67%
EPS 3Y-4.32%
EPS 5Y10.48%
EPS Q2Q%-0.66%
EPS Next Y-2.62%
EPS Next 2Y9.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.65%
Revenue growth 3Y-3.26%
Revenue growth 5Y8.31%
Sales Q2Q%-2.4%
Revenue Next Year3.57%
Revenue Next 2Y4.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.1%
EBIT growth 3Y-2.76%
EBIT growth 5Y18.15%
EBIT Next Year38.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.61%
FCF growth 3Y16.81%
FCF growth 5Y-11.58%
OCF growth 1Y-25.04%
OCF growth 3Y19.18%
OCF growth 5Y-1.06%

INNOSPEC INC / IOSP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOSPEC INC?

ChartMill assigns a fundamental rating of 6 / 10 to IOSP.


What is the valuation status of INNOSPEC INC (IOSP) stock?

ChartMill assigns a valuation rating of 5 / 10 to INNOSPEC INC (IOSP). This can be considered as Fairly Valued.


How profitable is INNOSPEC INC (IOSP) stock?

INNOSPEC INC (IOSP) has a profitability rating of 7 / 10.


What is the financial health of INNOSPEC INC (IOSP) stock?

The financial health rating of INNOSPEC INC (IOSP) is 8 / 10.


What is the expected EPS growth for INNOSPEC INC (IOSP) stock?

The Earnings per Share (EPS) of INNOSPEC INC (IOSP) is expected to decline by -2.62% in the next year.